Flavopiridol: where do we stand in chronic lymphocytic leukemia?

This publication has 43 references indexed in Scilit:

• Flavopiridol downregulates the expression of both the inducible NO synthase and p27kip1 in malignant cells from B-cell chronic lymphocytic leukemia
  Leukemia, 2003
• Leukemic and Non-Leukemic Lymphocytes from Patients with Li Fraumeni Syndrome Demonstrate Loss of p53 Function, Bcl-2 Family Dysregulation and Intrinsic Resistance to Conventional Chemotherapeutic Drugs But Not Flavopiridol
  Cell Cycle, 2003
• The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction
  Blood, 2002
• Seventy-Two Hour Continuous Infusion Flavopiridol in Relapsed and Refractory Mantle Cell Lymphoma
  Leukemia & Lymphoma, 2002
• Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
  New England Journal of Medicine, 2000
• Ionizing radiation activates the ATM kinase throughout the cell cycle
  Oncogene, 2000
• The controlling role of ATM in homologous recombinational repair of DNA damage
  The EMBO Journal, 2000
• Pleiotropic drug resistance in B-cell chronic lymphocytic leukaemia — the role of Bcl-2 family dysregulation
  Leukemia Research, 1999
• Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
  The Lancet, 1999
• Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275
  JNCI Journal of the National Cancer Institute, 1992